BioXcel Therapeutics Stock Price - BTAI

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
BioXcel Therapeutics Inc BTAI NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 6.24 0.00 0.00 0.00 6.24 07:19:12
Bid Price Ask Price Spread Spread % News
2.75 7.00 4.25 60.71% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

BioXcel Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 98.17M 15.73M $ -19.27M -1.33 - 15.54M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

BioXcel Therapeutics News

Date Time Source News Article
10/10/201908:00GlobeNewswire Inc.BioXcel Therapeutics Highlights Upcoming Major Milestones
9/30/201906:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/27/201917:31Edgar (US Regulatory)Current Report Filing (8-k)
9/26/201909:11GlobeNewswire Inc.BioXcel Therapeutics Announces Pricing of Public Offering of..
9/25/201916:58Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/25/201916:27GlobeNewswire Inc.BioXcel Therapeutics Announces Proposed Public Offering of..
9/25/201916:21Edgar (US Regulatory)Current Report Filing (8-k)

Latest BTAI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTAI Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week6.556.88655.86.241676k-0.31-4.73%
1 Month10.68125.87.5567126k-4.44-41.57%
3 Months1112.715.88.181161k-4.76-43.27%
6 Months10.6512.715.89.317551k-4.41-41.41%
1 Year6.3412.712.417.165472k-0.1-1.58%
3 Years11.0214.78992.418.070866k-4.78-43.38%
5 Years11.0214.78992.418.070866k-4.78-43.38%

BioXcel Therapeutics Description

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, which is a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company's other product candidates are BXCL502 and BXCL702 which is focused on neurodegeneration and hematological malignancies.
Your Recent History
NASDAQ
BTAI
BioXcel Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191014 12:50:08